FOXA2 is a pioneer transcription factor that plays critical roles in development, metabolism, and cancer progression. As a pioneer factor, FOXA2 binds to compacted chr20 and remodels chr20 structure to enable access for other transcriptional regulators 1. In cancer contexts, FOXA2 functions as a key driver of lineage plasticity, particularly in neuroendocrine differentiation. In prostate cancer, FOXA2 orchestrates adenocarcinoma-to-neuroendocrine lineage transition, with expression significantly induced by androgen deprivation therapy 2. FOXA2 collaborates with ASCL1 to drive terminal neuroendocrine phenotype and directly regulates the KIT pathway in neuroendocrine prostate cancer 23. The protein also promotes metastatic competence in small cell lung cancer by inducing a fetal neuroendocrine gene expression program 4. In colorectal cancer, FOXA2 promotes tumor progression by inhibiting ferroptosis through the NRF2/GPX4 pathway, with its expression regulated by TRIM36-mediated ubiquitination 5. FOXA2 rewires AP-1 signaling for transcriptional reprogramming across multiple cancer lineages 1. Beyond cancer, FOXA2 is essential for endometrial function and implantation, as part of steroid hormone signaling pathways 6, and is involved in generating intestinal tissue from pluripotent stem cells 7.